Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026
Salt Lake City
Archived
•
May 7, 2026
•
5 views
SALT LAKE CITY, May 7, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the first quarter ended March 31, 2026 and…
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
"Adventure is where you chose to go."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
